InflaRx N.V.

Contributing Author

Recent Articles by InflaRx N.V.

Oct-21	InflaRx Announces Participation in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference IFRX GlobeNewswire
Sep-12	InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement IFRX GlobeNewswire
Aug-21	InflaRx Announces Participation in September Investor Conferences IFRX GlobeNewswire
Aug-07	InflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update IFRX GlobeNewswire
Jul-31	InflaRx to Report Second Quarter 2025 Results on August 7, 2025 IFRX GlobeNewswire
Jul-11	InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement IFRX GlobeNewswire
May-28	InflaRx Announces Outcome of Interim Analysis for Vilobelimab Phase 3 Trial in Pyoderma Gangrenosum IFRX GlobeNewswire
May-22	InflaRx to Participate in Upcoming Investor Conferences IFRX GlobeNewswire
May-07	InflaRx Reports First Quarter 2025 Financial Results and Provides Business Update IFRX GlobeNewswire